(3S,6S,11R,17S,20S,23S,26S)-6-acetamido-17,23-bis[3-(diaminomethylideneamino)propyl]-20-(2-methylpropyl)-3-(2-methylsulfanylethyl)-2,5,13,16,19,22,25-heptaoxo-8,9-dithia-1,4,12,15,18,21,24-heptazatricyclo[24.8.0.027,32]tetratriaconta-27,29,31-triene-11-carboxamide

C43H69N15O9S3 — CID 70693247

IUPAC(3S,6S,11R,17S,20S,23S,26S)-6-acetamido-17,23-bis[3-(diaminomethylideneamino)propyl]-20-(2-methylpropyl)-3-(2-methylsulfanylethyl)-2,5,13,16,19,22,25-heptaoxo-8,9-dithia-1,4,12,15,18,21,24-heptazatricyclo[24.8.0.027,32]tetratriaconta-27,29,31-triene-11-carboxamide
SMILESCSCC[C@@H]1NC(=O)[C@H](NC(C)=O)CSSC[C@@H](C(N)=O)NC(=O)CNC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H]2c3ccccc3CCN2C1=O
InChIInChI=1S/C43H69N15O9S3/c1-23(2)19-30-38(64)54-27(11-7-15-49-42(45)46)36(62)51-20-33(60)53-31(35(44)61)21-69-70-22-32(52-24(3)59)39(65)56-29(14-18-68-4)41(67)58-17-13-25-9-5-6-10-26(25)34(58)40(66)55-28(37(63)57-30)12-8-16-50-43(47)48/h5-6,9-10,23,27-32,34H,7-8,11-22H2,1-4H3,(H2,44,61)(H,51,62)(H,52,59)(H,53,60)(H,54,64)(H,55,66)(H,56,65)(H,57,63)(H4,45,46,49)(H4,47,48,50)/t27-,28-,29-,30-,31-,32+,34-/m0/s1
InChIKeyZBGRRSXIHFNFOD-SOQBRSINSA-N
MW1036.32 g/mol
LogP-3.06
Rot. Bonds15

About (3S,6S,11R,17S,20S,23S,26S)-6-acetamido-17,23-bis[3-(diaminomethylideneamino)propyl]-20-(2-methylpropyl)-3-(2-methylsulfanylethyl)-2,5,13,16,19,22,25-heptaoxo-8,9-dithia-1,4,12,15,18,21,24-heptazatricyclo[24.8.0.027,32]tetratriaconta-27,29,31-triene-11-carboxamide

(3S,6S,11R,17S,20S,23S,26S)-6-acetamido-17,23-bis[3-(diaminomethylideneamino)propyl]-20-(2-methylpropyl)-3-(2-methylsulfanylethyl)-2,5,13,16,19,22,25-heptaoxo-8,9-dithia-1,4,12,15,18,21,24-heptazatricyclo[24.8.0.027,32]tetratriaconta-27,29,31-triene-11-carboxamide (PubChem CID 70693247) has the molecular formula C43H69N15O9S3 and a molecular weight of 1036.32 g/mol. Its IUPAC name is (3S,6S,11R,17S,20S,23S,26S)-6-acetamido-17,23-bis[3-(diaminomethylideneamino)propyl]-20-(2-methylpropyl)-3-(2-methylsulfanylethyl)-2,5,13,16,19,22,25-heptaoxo-8,9-dithia-1,4,12,15,18,21,24-heptazatricyclo[24.8.0.027,32]tetratriaconta-27,29,31-triene-11-carboxamide.

Molecular Properties

Compound Name(3S,6S,11R,17S,20S,23S,26S)-6-acetamido-17,23-bis[3-(diaminomethylideneamino)propyl]-20-(2-methylpropyl)-3-(2-methylsulfanylethyl)-2,5,13,16,19,22,25-heptaoxo-8,9-dithia-1,4,12,15,18,21,24-heptazatricyclo[24.8.0.027,32]tetratriaconta-27,29,31-triene-11-carboxamide
PubChem CID70693247
Molecular FormulaC43H69N15O9S3
Molecular Weight1036.32 g/mol
Exact Mass1035.46
IUPAC Name(3S,6S,11R,17S,20S,23S,26S)-6-acetamido-17,23-bis[3-(diaminomethylideneamino)propyl]-20-(2-methylpropyl)-3-(2-methylsulfanylethyl)-2,5,13,16,19,22,25-heptaoxo-8,9-dithia-1,4,12,15,18,21,24-heptazatricyclo[24.8.0.027,32]tetratriaconta-27,29,31-triene-11-carboxamide
SMILESCSCC[C@@H]1NC(=O)[C@H](NC(C)=O)CSSC[C@@H](C(N)=O)NC(=O)CNC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H]2c3ccccc3CCN2C1=O
InChIInChI=1S/C43H69N15O9S3/c1-23(2)19-30-38(64)54-27(11-7-15-49-42(45)46)36(62)51-20-33(60)53-31(35(44)61)21-69-70-22-32(52-24(3)59)39(65)56-29(14-18-68-4)41(67)58-17-13-25-9-5-6-10-26(25)34(58)40(66)55-28(37(63)57-30)12-8-16-50-43(47)48/h5-6,9-10,23,27-32,34H,7-8,11-22H2,1-4H3,(H2,44,61)(H,51,62)(H,52,59)(H,53,60)(H,54,64)(H,55,66)(H,56,65)(H,57,63)(H4,45,46,49)(H4,47,48,50)/t27-,28-,29-,30-,31-,32+,34-/m0/s1
InChIKeyZBGRRSXIHFNFOD-SOQBRSINSA-N
XLogP-3.06
TPSA395.90 Ų
H-Bond Donors12
H-Bond Acceptors14
Rotatable Bonds15
Heavy Atoms70
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001036.32
LogP ≤ 5-3.06
H-Bond Donors ≤ 512
H-Bond Acceptors ≤ 1014

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'disulphide', 'substructure': 'N/A'}, {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'imine_2', 'substructure': 'N/A'}

Analyze (3S,6S,11R,17S,20S,23S,26S)-6-acetamido-17,23-bis[3-(diaminomethylideneamino)propyl]-20-(2-methylpropyl)-3-(2-methylsulfanylethyl)-2,5,13,16,19,22,25-heptaoxo-8,9-dithia-1,4,12,15,18,21,24-heptazatricyclo[24.8.0.027,32]tetratriaconta-27,29,31-triene-11-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (3S,6S,11R,17S,20S,23S,26S)-6-acetamido-17,23-bis[3-(diaminomethylideneamino)propyl]-20-(2-methylpropyl)-3-(2-methylsulfanylethyl)-2,5,13,16,19,22,25-heptaoxo-8,9-dithia-1,4,12,15,18,21,24-heptazatricyclo[24.8.0.027,32]tetratriaconta-27,29,31-triene-11-carboxamide?
The IUPAC name of (3S,6S,11R,17S,20S,23S,26S)-6-acetamido-17,23-bis[3-(diaminomethylideneamino)propyl]-20-(2-methylpropyl)-3-(2-methylsulfanylethyl)-2,5,13,16,19,22,25-heptaoxo-8,9-dithia-1,4,12,15,18,21,24-heptazatricyclo[24.8.0.027,32]tetratriaconta-27,29,31-triene-11-carboxamide (CID 70693247) is (3S,6S,11R,17S,20S,23S,26S)-6-acetamido-17,23-bis[3-(diaminomethylideneamino)propyl]-20-(2-methylpropyl)-3-(2-methylsulfanylethyl)-2,5,13,16,19,22,25-heptaoxo-8,9-dithia-1,4,12,15,18,21,24-heptazatricyclo[24.8.0.027,32]tetratriaconta-27,29,31-triene-11-carboxamide.
What is the SMILES notation for (3S,6S,11R,17S,20S,23S,26S)-6-acetamido-17,23-bis[3-(diaminomethylideneamino)propyl]-20-(2-methylpropyl)-3-(2-methylsulfanylethyl)-2,5,13,16,19,22,25-heptaoxo-8,9-dithia-1,4,12,15,18,21,24-heptazatricyclo[24.8.0.027,32]tetratriaconta-27,29,31-triene-11-carboxamide?
The canonical SMILES for (3S,6S,11R,17S,20S,23S,26S)-6-acetamido-17,23-bis[3-(diaminomethylideneamino)propyl]-20-(2-methylpropyl)-3-(2-methylsulfanylethyl)-2,5,13,16,19,22,25-heptaoxo-8,9-dithia-1,4,12,15,18,21,24-heptazatricyclo[24.8.0.027,32]tetratriaconta-27,29,31-triene-11-carboxamide is CSCC[C@@H]1NC(=O)[C@H](NC(C)=O)CSSC[C@@H](C(N)=O)NC(=O)CNC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H]2c3ccccc3CCN2C1=O.
What is the InChIKey of (3S,6S,11R,17S,20S,23S,26S)-6-acetamido-17,23-bis[3-(diaminomethylideneamino)propyl]-20-(2-methylpropyl)-3-(2-methylsulfanylethyl)-2,5,13,16,19,22,25-heptaoxo-8,9-dithia-1,4,12,15,18,21,24-heptazatricyclo[24.8.0.027,32]tetratriaconta-27,29,31-triene-11-carboxamide?
The InChIKey is ZBGRRSXIHFNFOD-SOQBRSINSA-N. The full InChI is InChI=1S/C43H69N15O9S3/c1-23(2)19-30-38(64)54-27(11-7-15-49-42(45)46)36(62)51-20-33(60)53-31(35(44)61)21-69-70-22-32(52-24(3)59)39(65)56-29(14-18-68-4)41(67)58-17-13-25-9-5-6-10-26(25)34(58)40(66)55-28(37(63)57-30)12-8-16-50-43(47)48/h5-6,9-10,23,27-32,34H,7-8,11-22H2,1-4H3,(H2,44,61)(H,51,62)(H,52,59)(H,53,60)(H,54,64)(H,55,66)(H,56,65)(H,57,63)(H4,45,46,49)(H4,47,48,50)/t27-,28-,29-,30-,31-,32+,34-/m0/s1.
What are the key properties of (3S,6S,11R,17S,20S,23S,26S)-6-acetamido-17,23-bis[3-(diaminomethylideneamino)propyl]-20-(2-methylpropyl)-3-(2-methylsulfanylethyl)-2,5,13,16,19,22,25-heptaoxo-8,9-dithia-1,4,12,15,18,21,24-heptazatricyclo[24.8.0.027,32]tetratriaconta-27,29,31-triene-11-carboxamide?
(3S,6S,11R,17S,20S,23S,26S)-6-acetamido-17,23-bis[3-(diaminomethylideneamino)propyl]-20-(2-methylpropyl)-3-(2-methylsulfanylethyl)-2,5,13,16,19,22,25-heptaoxo-8,9-dithia-1,4,12,15,18,21,24-heptazatricyclo[24.8.0.027,32]tetratriaconta-27,29,31-triene-11-carboxamide has a molecular weight of 1036.32 g/mol, XLogP of -3.06, 15 rotatable bonds, 12 hydrogen bond donors, and 14 hydrogen bond acceptors.
Where does this data come from?
All data for (3S,6S,11R,17S,20S,23S,26S)-6-acetamido-17,23-bis[3-(diaminomethylideneamino)propyl]-20-(2-methylpropyl)-3-(2-methylsulfanylethyl)-2,5,13,16,19,22,25-heptaoxo-8,9-dithia-1,4,12,15,18,21,24-heptazatricyclo[24.8.0.027,32]tetratriaconta-27,29,31-triene-11-carboxamide is sourced from PubChem (CID 70693247), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).